Patent Number: 7,611,706

Title: RG1 antibodies and uses thereof

Abstract: The present invention relates to antibodies, and antigen-binding antibody fragments, directed against an RG1 polypeptide. The invention further relates to methods for utilizing the antibodies, and antibody fragments, for diagnostic and therapeutic applications.

Inventors: Harkins; Richard (Alameda, CA), Parkes; Deborah (Hayward, CA), Parry; Gordon (Oakland, CA), Parry; Renate (Oakland, CA), Schneider; Douglas (Lafayette, CA)

Assignee: Bayer Schering Pharma Aktiengesellschaft

International Classification: A61K 39/395 (20060101); C07H 21/04 (20060101); C07K 16/00 (20060101); C12P 21/04 (20060101); C12P 21/08 (20060101)

Expiration Date: 1/03/02017